Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Chemistry

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1373/clinchem.2010.143297PMID 20581083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.

  2009cited by this paper
• Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.

  2009cited by this paper
• Targeting the androgen receptor pathway in prostate cancer.

  2008cited by this paper
• Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

  2008cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening

  2006cited by this paper
• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

  2004cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

  2003cited by this paper
• Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

  2003cited by this paper
• A functional analysis of disease-associated mutations in the androgen receptor gene.

  2003cited by this paper
• Androgen receptor signaling in androgen-refractory prostate cancer.

  2001cited by this paper
• Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer

  1997cited by this paper
• Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography.

  1997cited by this paper
• Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

  1995cited by this paper

• Circulating tumour cells as a window into lethality in prostate cancer.

  2026cites this paper
• Harnessing the Potential of Nanotechnology for Liquid Biopsy of Cancer

  2025influential citation
• Liquid biopsies in cancer

  2025cites this paper
• Potentialities and challenges of liquid biopsy in clinical cancer management.

  2025cites this paper
• Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer

  2024cites this paper
• Liquid biopsy: paving a new avenue for cancer research

  2024cites this paper
• The efficacy and adverse events of conventional and second-generation androgen receptor inhibitors for castration-resistant prostate cancer: A network meta-analysis

  2023cites this paper
• siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway.

  2023cites this paper
• De Novo Design of an Androgen Receptor DNA Binding Domain‐Targeted peptide PROTAC for Prostate Cancer Therapy

  2022cites this paper
• Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer

  2022cites this paper
• Androgen receptor mutations for precision medicine in prostate cancer.

  2022cites this paper
• AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer.

  2021cites this paper
• Hormonal Therapy for Prostate Cancer.

  2021cites this paper
• The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects

  2021cites this paper
• Liquid Biopsy: From Discovery to Clinical Application.

  2021influential citation
• The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

  2020cites this paper
• Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy

  2020cites this paper
• O Papel da Biópsia Líquida no Cancro da Próstata Metastizado

  2020cites this paper
• Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival

  2020cites this paper
• Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer

  2019cites this paper
• Liquid biopsy and minimal residual disease — latest advances and implications for cure

  2019cites this paper
• Liquid biopsy for the detection and management of surgically resectable tumors

  2019cites this paper
• Molecular and Functional Characterization of Circulating Tumor Cells: From Discovery to Clinical Application.

  2019cites this paper
• MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.

  2019cites this paper
• Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration☆

  2018cites this paper
• Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer

  2018cites this paper
• Development and Application of Liquid Biopsies in Metastatic Prostate Cancer

  2018cites this paper
• Diagnostic Utility of miRNAs in Cancer

  2018cites this paper
• Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis

  2018cites this paper
• Review: Microfluidics technologies for blood-based cancer liquid biopsies.

  2018cites this paper
• Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation

  2018cites this paper
• Circulating tumor cell isolation, culture, and downstream molecular analysis.

  2018cites this paper
• Androgen action in prostate function and disease.

  2018cites this paper
• Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer

  2018cites this paper
• Circulating Tumor Cells: Enrichment and Genomic Applications

  2018cites this paper
• Circulating tumor cells in genitourinary tumors

  2018cites this paper
• Molecular characterization of circulating tumor cells-from bench to bedside.

  2017cites this paper
• EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression

  2017cites this paper
• Lessons from tissue compartment-specific analysis of androgen receptor alterations in prostate cancer.

  2017cites this paper
• Liquid Biopsies, What We Do Not Know (Yet).

  2017cites this paper
• CTCs and ctDNA: Two Tales of a Complex Biology

  2017cites this paper
• Circulating Tumor Cells as Cancer Biomarkers in the Clinic.

  2017cites this paper
• Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?

  2017cites this paper
• Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms.

  2017cites this paper
• Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.

  2017cites this paper
• Characterization of single circulating tumor cells

  2017cites this paper
• Circulating tumor cells in prostate cancer: Precision diagnosis and therapy

  2017influential citation
• Molecular Assays for the Detection and Molecular Characterization of CTCs

  2016cites this paper
• Circulating Tumor Cells and Tumor Dormancy

  2016cites this paper
• The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer.

  2016cites this paper
• New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer.

  2016cites this paper
• Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients

  2016cites this paper
• Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.

  2016cites this paper
• Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence.

  2016cites this paper
• Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies

  2016cites this paper
• Evaluation and consequences of heterogeneity in the circulating tumor cell compartment

  2016cites this paper
• Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?

  2016cites this paper
• Co‐introduction of a steroid with docetaxel chemotherapy for metastatic castration‐resistant prostate cancer affects PSA flare

  2016cites this paper
• Improving the CellSearch® system

  2016cites this paper
• Androgen receptor aberrations in the era of abiraterone and enzalutamide

  2016cites this paper
• Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?

  2016influential citation
• CELLSEARCH® Instrument, Features, and Usage

  2016cites this paper
• The promise of circulating tumor cells for precision cancer therapy.

  2016cites this paper
• BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients

  2016cites this paper
• Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial

  2015cites this paper
• When Prostate Cancer Circulates in the Bloodstream

  2015cites this paper
• Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.

  2015cites this paper
• Detecting predictive androgen receptor modifications in circulating prostate cancer cells

  2015cites this paper
• Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer

  2015cites this paper
• Circulating Tumor Cells: Enrichment and Genomic Applications

  2015cites this paper
• Development of enzalutamide for metastatic castration‐resistant prostate cancer

  2015cites this paper
• Analysis of circulating tumor cells derived from advanced gastric cancer

  2015cites this paper
• Using circulating tumor cells to inform on prostate cancer biology and clinical utility

  2015cites this paper
• Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

  2015cites this paper
• The Role of CTCs as Tumor Biomarkers.

  2015cites this paper
• Development of a Novel Method to Detect Prostate Cancer Circulating Tumor Cells (CTCs) Based on Epithelial-Mesenchymal Transition Biology

  2015cites this paper
• Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture.

  2014cites this paper
• Circulating tumour cells—monitoring treatment response in prostate cancer

  2014cites this paper
• Recent Advances in the Molecular Characterization of Circulating Tumor Cells

  2014cites this paper
• New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

  2014cites this paper
• KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer

  2014cites this paper
• Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?

  2014cites this paper
• Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

  2014influential citation
• Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

  2014cites this paper
• Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.

  2014cites this paper
• Challenges in circulating tumour cell research

  2014cites this paper
• Molecular analysis of circulating tumour cells—biology and biomarkers

  2014cites this paper
• Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

  2014cites this paper
• Cancer genetics: The origin and evolution of an ancient cancer

  2014cites this paper
• Circulating tumor cells as promising novel biomarkers in solid cancers

  2014cites this paper
• Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancer.

  2014cites this paper
• Circulating Tumor Cells as a Real-Time Liquid Biopsy: Isolation and Detection Systems, Molecular Characterization, and Clinical Applications

  2014cites this paper
• Circulating Tumor Cells: A Noninvasive Liquid Biopsy in Cancer

  2014cites this paper
• A novel approach for detecting viable and tissue‐specific circulating tumor cells through an adenovirus‐based reporter vector

  2014cites this paper
• Re: J. Alfred Witjes. A case of abiraterone acetate withdrawal. Eur urol 2013;64:517-8.

  2014cites this paper
• Perspectives on treatment of metastatic castration-resistant prostate cancer.

  2013cites this paper
• Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial.

  2013cites this paper
• Circulating Tumor Cells in Prostate Cancer

  2013cites this paper
• Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay 1 , 2

  2013cites this paper
• Anterior gradient 2 (AGR2): Blood‐based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype

  2013cites this paper